Found 7 matching trials
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)
PHASE3The goal of this clinical trial is to assess the effectiveness of GS010, a ...
Location
Doheny Eye Center, University of California, Los Angeles
Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year
PHASE3The goal of this clinical trial is to assess the efficacy and safety of GS0...
Location
Doheny Eye Center UCLA Pasadena
Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients
PHASE1The purpose of this study is to evaluate the safety and tolerability profil...
Location
CIC du CHNO DES QUINZE-VINGTS
EAP_GS010_single Patient
N/AExpanded Access Use for a single patient of Bilateral Intravitreal Injectio...
Status
No Longer Available
Location
Multiple Locations
Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients
PHASE2The goal of this Clinical trial is to assess the safety and efficacy of GS0...
Location
Hopital national des quinze-vingts
RESCUE and REVERSE Long-term Follow-up
PHASE3The goal of this clinical trial is to assess the long-term safety and effic...
Location
Doheny Eye Center UCLA
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
PHASE3The goal of this clinical trial is to assess the effectiveness of GS010, a ...
Location
Doheny Eye Center, University of California, Los Angeles